These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 7586147

  • 1. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ, Shane BS, Tindall KR, Cunningham ML.
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [Abstract] [Full Text] [Related]

  • 2. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
    Cunningham ML, Hayward JJ, Shane BS, Tindall KR.
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W, Ahiabor R, Blanco B, Locher F, Mantovani F, Robinson M, Sreenan G, Staedtler F, Swingler T, Vignutelli A, Perentes E.
    Environ Mol Mutagen; 1996 May; 28(4):354-62. PubMed ID: 8991064
    [Abstract] [Full Text] [Related]

  • 4. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR, Gorelick NJ, Andrews JL, de Boer JG, Glickman BW.
    Environ Mol Mutagen; 1996 May; 28(4):385-92. PubMed ID: 8991067
    [Abstract] [Full Text] [Related]

  • 5. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L, Saranko CJ, Steen AM.
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
    Dycaico MJ, Stuart GR, Tobal GM, de Boer JG, Glickman BW, Provost GS.
    Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
    [Abstract] [Full Text] [Related]

  • 13. Oxazepam is mutagenic in vivo in Big Blue transgenic mice.
    Shane BS, deBoer JG, Glickman BW, Cunningham ML.
    Carcinogenesis; 1999 Jul; 20(7):1315-21. PubMed ID: 10383906
    [Abstract] [Full Text] [Related]

  • 14. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
    Suzuki T, Itoh T, Hayashi M, Nishikawa Y, Ikezaki S, Furukawa F, Takahashi M, Sofuni T.
    Environ Mol Mutagen; 1996 Jul; 28(4):348-53. PubMed ID: 8991063
    [Abstract] [Full Text] [Related]

  • 15. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
    Bielas JH.
    Mutat Res; 2002 Jul 25; 518(2):107-12. PubMed ID: 12113761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interlaboratory comparison: liver spontaneous mutant frequency from lambda/lacI transgenic mice (Big Blue) (II).
    Young RR, Rogers BJ, Provost GS, Short JM, Putman DL.
    Mutat Res; 1995 Mar 25; 327(1-2):67-73. PubMed ID: 7870100
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ, Kort KL, Miller JE, Marino DR, Skopek TR.
    Mutat Res; 1998 Oct 12; 421(1):121-36. PubMed ID: 9748534
    [Abstract] [Full Text] [Related]

  • 19. Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens.
    Cunningham ML, Matthews HB.
    Toxicol Lett; 1995 Dec 12; 82-83():9-14. PubMed ID: 8597159
    [Abstract] [Full Text] [Related]

  • 20. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
    Knöll A, Jacobson DP, Nishino H, Kretz PL, Short JM, Sommer SS.
    Mutat Res; 1996 Jun 10; 352(1-2):9-22. PubMed ID: 8676922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.